| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/19/2013 | CN103159755A Alpha-glycosidase inhibitor preparation method and purpose |
| 06/19/2013 | CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor |
| 06/19/2013 | CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist |
| 06/19/2013 | CN103159651A Sulfonylurea guanidine and preparation method and application thereof |
| 06/19/2013 | CN103157112A Application of sialic acid derivatives in preparation of polyethylene glycol (PEG) lipid derivative modifying agent |
| 06/19/2013 | CN103157064A Preparation method of combination prescription for treating hepatitis |
| 06/19/2013 | CN103157059A Traditional Chinese medicine composition for treating hyperglycemia and hyperlipidemia |
| 06/19/2013 | CN103157025A Qi tonifying and yang elevating pill |
| 06/19/2013 | CN103157021A Medicament suitable for treating diabetes |
| 06/19/2013 | CN103157013A Herb tea for treating diabetes mellitus |
| 06/19/2013 | CN103157002A Pure traditional Chinese medicine composition for treating diabetes mellitus and preparation method for same |
| 06/19/2013 | CN103156998A Medicine for treating diabetes |
| 06/19/2013 | CN103156990A Traditional Chinese medicine for treating dispersion thirst with syndrome of lung dryness and body fluid impairment |
| 06/19/2013 | CN103156978A Drug for treatment of diabetes |
| 06/19/2013 | CN103156964A Capsule for hyperlipemia and its preparation method |
| 06/19/2013 | CN103156958A Weight reduction traditional Chinese medicine composition and preparation method thereof |
| 06/19/2013 | CN103156953A Blood circulation smoothing pill |
| 06/19/2013 | CN103156938A Hmong drug for treating diabetes mellitus |
| 06/19/2013 | CN103156910A Blood circulation smoothing bean |
| 06/19/2013 | CN103156869A Sanggenone C and sanggenone D extracted from morus plants and new medicine application of composition |
| 06/19/2013 | CN103156865A Application of L-arabinose in preparing medicines or health-care products |
| 06/19/2013 | CN103156861A Application of oleanolic acid derivative and pharmaceutically acceptable salts thereof in diabetic eye disease treatment |
| 06/19/2013 | CN103156847A Novel application of pitavastatin calcium |
| 06/19/2013 | CN103156845A Compounds having immunomodulator activity |
| 06/19/2013 | CN103156835A Drug for treatment of polycystic ovary syndrome (PCOS) and abnormal glucose metabolism coexisting diseases |
| 06/19/2013 | CN103156819A Benzoic acid alogliptin composition troche and preparation method thereof |
| 06/19/2013 | CN103156129A Black medical soybean food obtained by immersing black soybean through life-cultivating and health-care vinegar medical tea to carry out biological fermentation |
| 06/19/2013 | CN103156106A Lipid lowering and liver protecting drug or health food prepared by active ingredients of fructus schisandrae chinensis and preparation method |
| 06/19/2013 | CN102743350B Methionine-vitamin B1 composition injection and preparation method thereof |
| 06/19/2013 | CN102716150B Zinc sulfate syrup oral liquid preparation |
| 06/19/2013 | CN102698272B Medicinal composition for preventing diabetes, and application thereof |
| 06/19/2013 | CN102698271B Hypoglycemic drug composition and application thereof |
| 06/19/2013 | CN102698185B Traditional Tibetan medicine for treating hyperlipidemia and preparation method thereof |
| 06/19/2013 | CN102579397B Preparation method for vitamin A microcapsules |
| 06/19/2013 | CN102525950B Method for preparing pellets of Se-polysaccharides in Codonopsis pilosula |
| 06/19/2013 | CN102488846B Medicinal composition for treating diabetes mellitus |
| 06/19/2013 | CN102367227B Stable Levocarnitine compound and pharmaceutical composition thereof |
| 06/19/2013 | CN102356985B Medicinal pillow with effect of regulating blood fat |
| 06/19/2013 | CN102335269B Aromatase inhibitor |
| 06/19/2013 | CN102283873B Ultrasonic extraction method for saponin of Aralia elata blade |
| 06/19/2013 | CN102250342B PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
| 06/19/2013 | CN102240307B Preparation method of ginkgo leaf extract |
| 06/19/2013 | CN102178956B Preparation, medical application and composition of 20S-protopanaxadiol beta-cyclodextrin inclusion compound |
| 06/19/2013 | CN102170888B Paeoniflorin preparations and uses thereof for fat reduction |
| 06/19/2013 | CN102127062B Substituted isoandrographolide derivative, preparation method and medical application thereof |
| 06/19/2013 | CN101990535B Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators |
| 06/19/2013 | CN101967094B Phenylacetyl quinic acid of witlooves and ester compound thereof |
| 06/19/2013 | CN101914168B Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof |
| 06/19/2013 | CN101910189B Monosebacate of pyrazole derivative |
| 06/19/2013 | CN101880276B Substituted diazepan compounds as orexin receptor antagonists |
| 06/19/2013 | CN101790531B Process for the preparation of pyrido [2, 1-alpha] isoquinoline derivatives and polymorphic froms thereof |
| 06/19/2013 | CN101616680B Agent for reducing visceral fat |
| 06/19/2013 | CN101594871B Pyrrolopyrimidine compounds and their uses |
| 06/19/2013 | CN101422443B Fenofibrate osmotic pump controlled release preparation and preparation method thereof |
| 06/19/2013 | CN101411711B Composition containing alisol A and alisol A 24-acetic ester and use |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466103 Exendin polypeptide linked to biotin, method for the preparation thereof and pharmaceutical composition comprising the same |
| 06/18/2013 | US8465468 Intradermal delivery of substances |
| 06/18/2013 | CA2718007C The use of medium chain dicarboxylic acids and derivates thereof in the treatment of metabolic disorders |
| 06/18/2013 | CA2683695C 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives |
| 06/18/2013 | CA2595218C Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
| 06/18/2013 | CA2418144C Urocortin proteins and uses thereof |
| 06/13/2013 | WO2013086515A1 Compositions and methods for the prevention or treatment of diabetic complications |
| 06/13/2013 | WO2013086443A1 Agonistic human lcat antigen binding proteins and their use in therapy |
| 06/13/2013 | WO2013086143A1 Modified mini-hepcidin peptides and methods of using thereof |
| 06/13/2013 | WO2013085957A1 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors |
| 06/13/2013 | WO2013085338A2 Pharmaceutical composition for preventing and treating metabolic diseases, comprising nymphaea tetragona root extract, fractions thereof, or polyphenol-based compounds isolated from the nymphaea tetragona root extract as active ingredients |
| 06/13/2013 | WO2013085330A1 Composition for treatment or prevention of hyperlipidemia, containing water extracts of laetiporus sulphureus |
| 06/13/2013 | WO2013085328A1 Composition for treatment or prevention of hyperlipidemia, containing alcohol extracts of oligoporus tephroleucus |
| 06/13/2013 | WO2013085326A1 Composition for treatment or prevention of obesity, containing water extracts of tremella foliacea |
| 06/13/2013 | WO2013085322A1 Composition for treatment or prevention of obesity, containing alcohol extracts of hapalopilus rutilans |
| 06/13/2013 | WO2013085308A1 Composition for treatment or prevention of hyperlipidemia, containing ethanol extracts of albatrellus dispansus |
| 06/13/2013 | WO2013085059A1 Method for producing nutritional composition |
| 06/13/2013 | WO2013085018A1 Phenylpyrrole derivative |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013084971A1 Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof |
| 06/13/2013 | WO2013084816A1 Agent for preventing and/or treating veisalgia |
| 06/13/2013 | WO2013084532A1 Prophylactic or therapeutic agent for dysuria |
| 06/13/2013 | WO2013084249A1 Dietary supplement comprising verbascoside and teupolioside for lowering ldl and increasing hdl |
| 06/13/2013 | WO2013084237A1 Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof |
| 06/13/2013 | WO2013084210A1 Amorphous form of sitagliptin salts |
| 06/13/2013 | WO2013083775A1 New compounds, pharmaceutical compositions and uses thereof |
| 06/13/2013 | WO2013083674A1 Novel pharmaceutical statin composition |
| 06/13/2013 | WO2013083041A1 Microspheres for controlled- or sustained-release delivery of therapeutics |
| 06/13/2013 | WO2013082756A1 Phosphate transport inhibitors ii |
| 06/13/2013 | WO2013082751A1 Phosphate transport inhibitors i |
| 06/13/2013 | WO2013058631A3 Diterpene furanoids compound which inhibits protein tyrosine phosphatase 1b and the use thereof |
| 06/13/2013 | WO2013022312A3 Pharmaceutical composition for preventing or treating diabetes or fatty liver containing a cyp4a inhibitor as an active ingredient |
| 06/13/2013 | WO2013016544A4 Templated islet cells and small islet cell clusters for diabetes treatment |
| 06/13/2013 | WO2012177593A3 Method for treating obesity |
| 06/13/2013 | US20130150311 Mixed poloxamer excipients |
| 06/13/2013 | US20130150296 Albumin fusion proteins |
| 06/13/2013 | CA2858572A1 Agonistic human lcat antigen binding proteins and their use in therapy |
| 06/13/2013 | CA2858342A1 Phenylpyrrole derivative |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2855122A1 Modified mini-hepcidin peptides and methods of using thereof |
| 06/12/2013 | EP2602259A2 Salt of proline derivative, solvate thereof, and production method thereof |
| 06/12/2013 | EP2602255A1 Fused heterocyclic ring compound |
| 06/12/2013 | EP2602254A1 Heterocyclic compound |